Speaker:

Shalini Bansil , Resident Physician, Neurology staff member, Geisinger - has nothing to disclose.
 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 
 
  • Evaluate the risks and benefits of high efficacy immunomodulating therapies in older patients with multiple sclerosis
  • Determine strategies to deescalate immunomodulating therapies in older patients with multiple sclerosis

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Dana Vanino, DO, Joy Hill, RN, Karen Tillotson, PA-C and Kristy Heim have no identified disclosures. 
 

CE Committee Member/Content Reviewers have nothing to disclose.

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 
 

Commerical Support for this Session

None
Session date: 
09/25/2024 - 12:00pm to 1:00pm EDT
Location: 
Geisinger Medical Center
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation Credit

Please login or register to take this course.